p53 and c-myc expression in stage A1 prostatic adenocarcinoma: useful prognostic determinants?
暂无分享,去创建一个
C. Collins | S. Fox | P. Silcocks | J. Royds | R. Persad | S B Fox | P B Silcocks | C C Collins | R A Persad | J Royds | R N Kore | C. Collins | R. Kore | J. Royds
[1] J. Waxman,et al. The current status of scientific research and hormonal treatments for carcinoma of the prostate. , 1991, British Journal of Cancer.
[2] C. Eaton,et al. Growth factor involvement and oncogene expression in prostatic tumours. , 1988, Journal of steroid biochemistry.
[3] J D Siegal,et al. Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancers , 1988, The Prostate.
[4] P. Walsh,et al. Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. , 1981, The Journal of urology.
[5] P. Scardino,et al. The risk of dying of prostate cancer in patients with clinically localized disease. , 1991, The Journal of urology.
[6] W. Isaacs,et al. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. , 1991, Cancer research.
[7] Y. Reinberg,et al. Long-term followup results after expectant management of stage A1 prostatic cancer. , 1991, The Journal of urology.
[8] P. Walsh,et al. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup. , 1986, The Journal of urology.
[9] C. Marshall. Tumor suppressor genes , 1991, Cell.
[10] A. Harris. Mutant p53—the commonest genetic abnormality in human cancer? , 1990, The Journal of pathology.
[11] A. Harris,et al. Increased expression of mutant forms of p53 oncogene in primary lung cancer , 1990, The Lancet.
[12] R. Eisenman,et al. V-myc- and c-myc-encoded proteins are associated with the nuclear matrix , 1985, Molecular and cellular biology.
[13] R. Cohen,et al. Prostatic carcinoma: histological and immunohistological factors affecting prognosis. , 1990, British journal of urology.
[14] M. Blute,et al. Long-term followup of young patients with stage A adenocarcinoma of the prostate. , 1986, The Journal of urology.
[15] P. Walsh,et al. Cancer control following anatomical radical prostatectomy: an interim report. , 1991, The Journal of urology.
[16] J. McNeal,et al. Origin and development of carcinoma in the prostate , 1969, Cancer.
[17] S. Polacarz,et al. Endocervical carcinoma and precursor lesions: c-myc expression and the demonstration of field changes. , 1991, Journal of clinical pathology.
[18] P. Smith,et al. Intranuclear androgen receptor deployment and protooncogene expression in human diseased prostate. , 1987, Urologia internationalis.
[19] G. Hanks. External beam radiation therapy for prostate cancer clinically confined to the gland. , 1989, Urology.
[20] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[21] R. Scott,et al. Carcinoma of the prostate in elderly men: incidence, growth characteristics and clinical significance. , 1969, The Journal of urology.
[22] R. Matusik,et al. Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia. , 1986, Cancer research.
[23] M. Groudine,et al. Control of c-myc regulation in normal and neoplastic cells. , 1991, Advances in cancer research.
[24] P G Mulder,et al. Histological grading of prostatic carcinoma in prostatectomy specimens. Comparison of prognostic accuracy of five grading systems. , 1990, British journal of urology.
[25] T. Thompson. Growth factors and oncogenes in prostate cancer. , 1990, Cancer cells.
[26] A. Klein-Szanto,et al. Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines. , 1991, The American journal of pathology.
[27] A. Levine,et al. The p53 tumour suppressor gene , 1991, Nature.
[28] D. Brachman,et al. Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes , 1991, Journal of surgical oncology.
[29] D. Horsfall,et al. The prognostic value of deoxyribonucleic acid flow cytometric analysis in stage D2 prostatic carcinoma. , 1991, The Journal of urology.
[30] A. Busuttil,et al. Age, and size and grade of tumour predict prognosis in incidentally diagnosed carcinoma of the prostate. , 1988, British journal of urology.
[31] J. Marks,et al. Genetic basis for p53 overexpression in human breast cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[32] N. Lemoine,et al. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer. , 1991, British Journal of Cancer.
[33] R. Cohen,et al. Neuro-endocrine cells--a new prognostic parameter in prostate cancer. , 1991, British journal of urology.
[34] R. M. Sharrard,et al. Cellular localisation of C‐myc product in human colorectal epithelial neoplasia , 1992, The Journal of pathology.